Veeva Systems (NYSE:VEEV – Get Free Report) had its target price cut by stock analysts at UBS Group from $280.00 to $200.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has a “neutral” rating on the technology company’s stock. UBS Group’s price target suggests a potential upside of 10.83% from the stock’s current price.
Other research analysts also recently issued research reports about the company. Morgan Stanley raised Veeva Systems from an “underweight” rating to an “equal weight” rating and decreased their price objective for the stock from $222.00 to $205.00 in a research note on Tuesday, February 17th. Citigroup cut their price objective on Veeva Systems from $349.00 to $319.00 and set a “buy” rating for the company in a research note on Monday, November 24th. Barclays decreased their target price on shares of Veeva Systems from $325.00 to $305.00 and set an “overweight” rating on the stock in a research note on Friday, November 21st. BMO Capital Markets assumed coverage on shares of Veeva Systems in a report on Thursday, November 13th. They set a “market perform” rating and a $300.00 price target on the stock. Finally, The Goldman Sachs Group assumed coverage on shares of Veeva Systems in a research report on Tuesday, January 13th. They issued a “sell” rating and a $215.00 price target for the company. Eighteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $302.58.
Get Our Latest Analysis on Veeva Systems
Veeva Systems Price Performance
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its earnings results on Thursday, November 20th. The technology company reported $2.04 EPS for the quarter, topping analysts’ consensus estimates of $1.95 by $0.09. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The company had revenue of $0.81 million for the quarter, compared to analysts’ expectations of $792.37 million. During the same period last year, the firm earned $1.75 EPS. Veeva Systems’s revenue for the quarter was up 16.0% compared to the same quarter last year. Equities research analysts expect that Veeva Systems will post 4.35 EPS for the current year.
Veeva Systems declared that its board has authorized a stock buyback program on Monday, January 5th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the technology company to repurchase up to 5.5% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.
Insider Transactions at Veeva Systems
In other news, insider Thomas D. Schwenger sold 1,000 shares of Veeva Systems stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total transaction of $231,430.00. Following the sale, the insider owned 23,204 shares in the company, valued at $5,370,101.72. This trade represents a 4.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 10.30% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Veeva Systems
Hedge funds and other institutional investors have recently modified their holdings of the stock. Jensen Investment Management Inc. lifted its holdings in shares of Veeva Systems by 1,924.5% in the 3rd quarter. Jensen Investment Management Inc. now owns 413,213 shares of the technology company’s stock valued at $123,100,000 after acquiring an additional 392,802 shares during the last quarter. Principal Financial Group Inc. raised its position in Veeva Systems by 11.2% during the third quarter. Principal Financial Group Inc. now owns 3,846,877 shares of the technology company’s stock valued at $1,146,040,000 after purchasing an additional 388,864 shares during the period. Alphinity Investment Management Pty Ltd purchased a new stake in Veeva Systems during the third quarter valued at approximately $422,241,000. Compass Wealth Management LLC bought a new stake in shares of Veeva Systems in the 3rd quarter valued at approximately $18,694,000. Finally, ABN AMRO Bank N.V. purchased a new position in shares of Veeva Systems in the 3rd quarter worth approximately $246,625,000. Institutional investors own 88.20% of the company’s stock.
Veeva Systems News Summary
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: RBC Capital reiterated its Buy stance on VEEV, signaling continued institutional confidence in Veeva’s growth profile and commercial software exposure. RBC Sticks to Buy
- Positive Sentiment: Morgan Stanley upgraded VEEV (upgrade reported), adding upward analyst support that can attract buyers who follow institutional ratings. Morgan Stanley Upgrade
- Positive Sentiment: Veeva closed higher in the most recent session, showing short-term buying interest after recent weakness. Veeva Closes Higher
- Neutral Sentiment: JPMorgan trimmed its price target from $330 to $296 but kept an Overweight rating — a signal that the bank still sees upside even while moderating expectations. JPMorgan PT Cut
- Neutral Sentiment: UBS lowered its target from $280 to $200 and moved to a Neutral rating — reducing near-term upside from that shop and likely tempering enthusiasm from UBS-following investors. UBS PT Cut
- Neutral Sentiment: Analyst/opinion pieces weigh two reasons to like VEEV (platform strength, recurring revenue) against one concern — signaling a balanced view for investors considering re-entry after recent losses. 2 Reasons to Like VEEV
- Negative Sentiment: Asset managers cite a broader sector rotation out of technology and software, which has pressured Veeva alongside peers — a macro/flow-driven headwind that can keep volatility elevated. Sector Rotation
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
See Also
- Five stocks we like better than Veeva Systems
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
